Trial · NCT06000137
The Comparison of the Analgesic Effects of Dezocine and Sufentanil in Patient-controlled Analgesia After Laryngectomy
NCT06000137, Not applicable, Completed, Eye & ENT Hospital of Fudan University
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. The Comparison of the Analgesic Effects of Dezocine and Sufentanil in Patient-controlled Analgesia After Laryngectomy. Trials, record NCT06000137. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06000137
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Comparison of the Analgesic Effects of Dezocine and Sufentanil in Patient-controlled Analgesia After Laryngectomy
- NCT number
- NCT06000137
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 129 participants, actual
- Lead sponsor
- Eye & ENT Hospital of Fudan University
- Conditions
- Patient-controlled Analgesia
- Interventions
- Dezocine, Sufentanil injection, Flurbiprofen, Granisetron Injection
- First posted
- 2023-08-21
- Last updated
- 2023-08-21
Source ClinicalTrials.gov
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | total | from the end of the surgery to 48 hours after surgery | no pain =0, mild pain =1-3, moderate pain =4-6, and severe pain =7-10 |
| Secondary | 24 hours amount of drug | From the time of use postoperative analgesic to the time of 24 hours after the surgery | the volume of postoperative analgesic in 24 hours after the surgery |
| Secondary | 48 hours pressing times of Patient-controlled Analgesia | From the time of use postoperative analgesic to the time of 48 hours after the surgery | the times of press analgesia pump in 24 hours after the surgery |
| Secondary | Visual Analogue Scale | at the time of 6 hours after the surgery | no pain =0, mild pain =1-3, moderate pain =4-6, and severe pain =7-10 |
| Secondary | Visual Analogue Scale | at the time of 12 hours after the surgery | no pain =0, mild pain =1-3, moderate pain =4-6, and severe pain =7-10 |
| Secondary | Visual Analogue Scale | at the time of 24 hours after the surgery | no pain =0, mild pain =1-3, moderate pain =4-6, and severe pain =7-10 |
| Secondary | Visual Analogue Scale | at the time of 48 hours after the surgery | no pain =0, mild pain =1-3, moderate pain =4-6, and severe pain =7-10 |
| Secondary | the incidence of nausea | from the time when patients use postoperative analgesic to the time when patients stop to use postoperative analgesic, assessed up to 48 hours | the incidence of nausea |
| Secondary | the incidence of vomiting | from the time when patients use postoperative analgesic to the time when patients stop to use postoperative analgesic, assessed up to 48 hours | the incidence of vomiting |
| Secondary | the incidence of dizziness | from the time when patients use postoperative analgesic to the time when patients stop to use postoperative analgesic, assessed up to 48 hours | the incidence of dizziness |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers10
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06000137
GET https://conductscience.org/api/trials/v1/NCT06000137/registered